| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/10/2007 | EP1740164A1 Statins for the treatment of ocular hypertension and glaucoma |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1200073B1 SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE |
| 01/10/2007 | EP0983084B1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders |
| 01/10/2007 | CN1894244A Aryl ether substituted imidazoquinolines |
| 01/10/2007 | CN1893932A Microemulsion preconcentrate comprising a renin inhibitor |
| 01/10/2007 | CN1891245A Centella soft capsule and its preparing method |
| 01/10/2007 | CN1891220A 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 01/10/2007 | CN1294135C Pyrrolopyrimidines as protein kinase inhitibors |
| 01/10/2007 | CN1294133C Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293880C Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 01/10/2007 | CN1293878C Preventing or therapeutic agent for eye fatigue and pseudomyopia |
| 01/10/2007 | CN1293865C Cell growth regulating factor R and its preparation process |
| 01/09/2007 | US7160922 Biphenyl-4-carboxylic acid-(6-(1-((4-fluorobenzyl)methylamino)ethylideneamino)-2-hydroxyindan-1-yl)amide; cognitive activators, attention deficit/hyperactivity disorder, obesity, Alzheimer's disease, psychoses, schizophrenia; hypotensive agents for glaucoma |
| 01/09/2007 | US7160904 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 01/09/2007 | US7160894 Antagonist of phosphorylation of myosin regulatory light chain, enzyme inhibitors; therapeutic treatment of glaucoma, bronchial asthma, chronic obstructive pulmonary disease, nervous system disorders; 4-(2,3-dihydro-1,5-diazaphenalen-1-yl)cyclohexylamine |
| 01/09/2007 | US7160892 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 01/09/2007 | US7160889 Quinazoline compounds |
| 01/09/2007 | US7160873 Texaphyrin coordination compounds and uses thereof |
| 01/09/2007 | US7160685 Peptides having SEQ ID NO: 2 with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |
| 01/09/2007 | CA2176511C Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 01/04/2007 | WO2007002670A2 Method of lowering intraocular pressure |
| 01/04/2007 | WO2007000924A1 Pharmaceutical composition comprising substance capable of inhibiting or promoting progranulin activity and screening method for substance capable of inhibiting or promoting progranulin activity |
| 01/04/2007 | WO2007000642A1 Fluoroprostaglandins nitroderivatives |
| 01/04/2007 | WO2007000240A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 01/04/2007 | US20070004807 Methods using phenethanolamine derivatives for treatment of respiratory diseases |
| 01/04/2007 | US20070004788 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
| 01/04/2007 | US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 01/04/2007 | US20070004740 phosphodiesterase 4 inhibitors which are naphthalene compounds such as 6,7-Dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene; asthma or inflammatory diseases |
| 01/04/2007 | US20070004739 Condensed polycyclic compounds |
| 01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004698 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 01/04/2007 | US20070003630 Anti-angiogenic compositions and methods of use |
| 01/04/2007 | US20070003629 Anticancer agents; prevent forming blood vessels; removal blockage |
| 01/04/2007 | US20070003578 Chimeric protein comprising non-toxic pseudomonas exotoxin and type IV pilin sequences |
| 01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
| 01/04/2007 | US20070003524 Targeted retrograde gene delivery to motor neurons |
| 01/04/2007 | CA2613748A1 Prostaglandin derivatives |
| 01/04/2007 | CA2613010A1 Fluoroprostaglandins nitroderivatives |
| 01/04/2007 | CA2611295A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 01/04/2007 | CA2608476A1 Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of gelatinase a in ocular cells |
| 01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1738767A1 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 01/03/2007 | EP1737479A1 Therapeutic administration of the scrambled anti-angiogenic peptide c16y |
| 01/03/2007 | EP1737412A2 Use of sulfated hyaluronic acid |
| 01/03/2007 | EP1511765B1 Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 01/03/2007 | EP1347780B1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 01/03/2007 | EP1267826B1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/03/2007 | EP1212071B1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 01/03/2007 | CN1890220A A crystalline of the salt form of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same |
| 01/03/2007 | CN1889997A Compounds for the treatment of ocular dryness caused by photorefractive surgery |
| 01/03/2007 | CN1889954A Prevention and/or reduction of photoreceptor degeneration with retinoids |
| 01/03/2007 | CN1887352A Composition for treating eye's fungal and bacterial infection |
| 01/03/2007 | CN1887290A Lincomycin hydrochloride composition and its prepn |
| 01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
| 01/03/2007 | CN1293071C Benzo [g] quinoline derivatives for treating glaucoma and myopia |
| 01/03/2007 | CN1293070C Quinoline derivatives |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/03/2007 | CN1292752C Solutions containing epinastine |
| 01/03/2007 | CN1292721C Drug delivery device |
| 01/02/2007 | US7157582 For example, 3S,4aR,6S,8aR Ethyl 6-(((5S)-5-(Ethoxycarbonyl)-3-oxopyrrolidinyl) methyl)-2-methoxycarbonyl-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylate; for treating or preventing migraine |
| 01/02/2007 | US7157487 Vla-4 inhibitors |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157453 Urea substituted imidazoquinolines |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | CA2376668C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 12/28/2006 | WO2006138038A1 Intralesional treatment of psoriasis |
| 12/28/2006 | WO2006137469A1 Metabotropic glutamate receptor activator |
| 12/28/2006 | WO2006137465A1 Nitrogenated heterocyclic derivative |
| 12/28/2006 | WO2006137426A1 Prophylactic or therapeutic agent for corneal/conjunctival disease |
| 12/28/2006 | WO2006137421A1 Agent for topical administration |
| 12/28/2006 | WO2006137368A1 Preventive or remedy for glaucoma |
| 12/28/2006 | WO2006137341A1 Agent for visualizing vitreous body |
| 12/28/2006 | WO2006136116A1 Use of interferon-alpha in order to obtain a compound for the treatment of optical neuromyelitis |
| 12/28/2006 | WO2006098918B1 Substituted gamma lactams as therapeutic agents |
| 12/28/2006 | US20060293543 Isolation of lutein from alfalfa |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293347 Pharmaceutically active compounds |
| 12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293282 Substituted aminoalkanephosphonic acids |
| 12/28/2006 | US20060293275 Hgf production accelerator containing heparin-like oligosaccharide |
| 12/28/2006 | US20060293252 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 12/28/2006 | US20060293221 Mucosal repair by TFF2 peptides |
| 12/28/2006 | US20060292622 determining the presence of or predisposition to early-onset spinocerebellar ataxia with ocular motor aprataxia and hypoalbuminemia in a human; neurodegenerative disease |
| 12/28/2006 | US20060292613 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions |
| 12/28/2006 | CA2633030A1 Intralesional treatment of psoriasis |
| 12/28/2006 | CA2613247A1 Prophylactic or therapeutic agent for corneal/conjunctival disease |
| 12/28/2006 | CA2613244A1 Vitreous body visualization agent |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736468A2 Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation |